Prostate Cancer News and reporting on prostate cancer. 23andMe Gains FDA Clearance for Direct-to-Consumer Prostate Cancer Genetic Risk Test The firm is now authorized to sell a genetic health report on the HOXB13 marker that indicates risk for hereditary prostate cancer, its third DTC cancer risk report with 510(k) clearance. Rarecells Raises $13M in Series A Round to Develop Liquid Biopsy Early Cancer Detection Tests The company is planning to develop circulating tumor cell assays for prostate cancer and acute myeloid leukemia and to launch them in the US. Angle Readies for Clinical Testing as CTC Research Continues to Yield Biomarker Insights Premium The company is embarking on its own diagnostic plans as it prepares to market its platform for external test development following FDA clearance. Caris Life Sciences, Essa Pharma Ink Liquid Biopsy Partnership for Prostate Cancer Trial Essa will use Caris' blood-based sequencing tests to assess the genetic profiles of mCRPC patients enrolled in a Phase I trial of the firm's investigational agent. Polygenic Risk Scores for Breast, Prostate Cancer Adaptable for Cross-Ancestry Use, Study Shows The researchers said the approach could be a short-term measure while genetic studies of more diverse ancestral populations are performed. Aug 26, 2021 MDxHealth H1 2021 Revenues Up 9 Percent As Testing Volumes Rebound Aug 3, 2021 Burning Rock Biotech, Impact Therapeutics Partner on CDx for PARP Inhibitor Senaparib Jul 30, 2021 Veracyte Aims to Broaden Reach of Decipher Prostate Assay as Studies Continue to Expand Utility Premium Jul 29, 2021 Veracyte Q2 Revenues More Than Double on Test Volume Spike Jul 28, 2021 Capio Biosciences, BioView to Explore Integration of Circulating Tumor Cell Technologies Jun 4, 2021 Genomic Differences in Prostate Cancer Found Among African Americans, European Americans May 21, 2021 Palmetto Releases Draft LCD for Prostate Cancer Risk Stratification Tests May 6, 2021 Bio-Techne Fiscal Q3 Revenues Rise 25 Percent as End Markets Improve Apr 20, 2021 Prostate Cancer Study Shows Oncotype DX GPS Test Accurately Measures Long-Term Outcomes Premium Apr 14, 2021 Guardant AACR Data Highlights Value of Clinical Test Database to Drive Drug Resistance Discoveries Mar 23, 2021 Bio-Techne Obtains CE Mark for Exosomal Liquid Biopsy Prostate Test Mar 17, 2021 Bio-Techne Seeks to Build Out 'Substantial Diagnostics Presence' With Asuragen Buy Premium Mar 10, 2021 Datar Cancer Genetics Obtains CE Mark for Liquid Biopsy Cancer Test Mar 3, 2021 MDxHealth 2020 Revenues Up 57 Percent Mar 2, 2021 Oppenheimer Initiates Coverage of MDxHealth at Outperform Mar 1, 2021 Bio-Techne Obtains Reimbursement Contract With Humana for Exosome Diagnostics Prostate Biopsy Test Feb 3, 2021 Veracyte to Acquire Decipher Biosciences for $600M; Prelim Q4 Revenues Grow 14 to 18 Percent Feb 2, 2021 Bio-Techne Fiscal Q2 Revenues Rise 21 Percent Jan 4, 2021 Genetic Score Predicts Prostate Cancer Risk Across Ancestry Populations Nov 25, 2020 European Consortium Seeks to Develop Liquid Biopsy Test for Prostate, Testicular Cancer Premium Load More Breaking News In Ongoing False Advertising Suit, Judge Allows Natera Counterclaims Against Guardant Health Centogene Strikes Rare Disease Target Discovery Deal With Insilico Medicine Dilated Cardiomyopathy Gene Mutations Point to Possible Therapeutic Strategy Ginkgo Bioworks Acquires Massachusetts COVID-19 Testing Firm Mainz Biomed Taps DCN Dx to Aid European Study of Enhanced ColoAlert Assay Parse Biosciences Partners With Research Instruments for Southeast Asia Distribution The Scan Transplant Tests Edited Pig Kidneys The Associated Press reports a University of Alabama-Birmingham team transplanted genetically modified pig kidneys into a brain-dead human patient. UK Changes Some Gene-Edited Crop Rules A new law may enable gene-edited crops to be sold in the UK within about five years, New Scientist says. Pill Works Against Omicron in Lab Pfizer's antiviral pill to treat SARS-CoV-2 appears to work against the Omicron variant, the Wall Street Journal reports. Nature Papers Find Genetic Risk Factor for Smell, Taste Loss in COVID-19; Analyze TB Granulomas In Nature this week: genome-wide association study find locus linked to the risk COVID-19 patients losing their sense of taste or smell, and more.